Abstract
FT-IR and Raman spectra of 1-cyclopentylpiperazine (1cppp) have been experimentally examined in the region of 4000-200 cm−1. The optimized geometric parameters, conformational equilibria, normal mode frequencies and corresponding vibrational assignments of 1cppp (C9H18N2) are theoretically examined by means of B3LYP hybrid density functional theory (DFT) method together with 6-31++G (d, p) basis set. On the basis of potential energy distribution (PED) reliable vibrational assignments have been made and the thermodynamics functions, highest occupied and lowest unoccupied molecular orbitals (HOMO and LUMO) of 1cppp have been predicted. Calculations are employed for four different conformations in C1 and Cs point groups of 1cppp in gas phase. Comparison between the experimental and theoretical results indicates that B3LYP method is able to provide satisfactory results for predicting vibrational frequencies and the structural parameters, vibrational frequencies and assignments. Furthermore, C1 (equatorial-axial) point group has been found as the most stable conformer of 1cppp.
Similar content being viewed by others
References
Zaragoza F, Stephensen H, Peschke B, et al. 2-(4-Alkylpiperazin-1-yl)quinolines as a new class of imidazole-free histamine H3 receptor antagonists. J Med Chem, 2005, 48: 306–311
Nettekoven M H, Roche O. Piperazinyl pyridine derivatives as anti-obesity agents. European Patent Specification, EP 1828134B1, 2008-10-29
Cooper J, Duan M, Grimes R, et al. Compounds. US Patent, US 2010/0196321A1, 2010-08-05
De Johnge S, Dolusic E, Gao L J, et al. Pyrido(3, 2-D)pyrimidines and pharmaceutical compositions useful for medical treatment. US Patent, US 2008/0004285A1, 2008-01-03
Petersen U, Grohe K, Zeiler H J, et al. 1-Cyclopropyl-6-fluoro-1, 4-dihydro-4-oxo-7-(1-piperazinyll)-3-quinolinecarboxykic acids and antibacterial agents containing them. US Patent, 4.806.539, 1989-02-21
Matsuo M, Manabe T, Konishi N, et al. Piperazine derivatives as tachykinin antagonists. US Patent, 6.087.357, 2000-07-11
Johnson K W, Phebus L A. Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F. US Patent, 5.962.473, 1999-10-05
Baiji A C, Kim S H, Markovitz B, et al. Therapeutic compounds and their use in cancer. US Patent, US 2010/0016586A1, 2010-01-21
Nettekoven M H, Roche O. Piperidinyl pyrimidine derivatives. US Patent, US 2007/0281921A1, 2007-12-06
Taracido I C, Harrington E M, Lattmann R, et al. Imidazo pyridine derivatives. US Patent, US 2009/0291942, 2009-11-26
Xie L, Ochterski J W, Gao Y, et al. Dipiperazinyl ketones and related analogues. US Patent, US 2007/0049571A1, 2007-03-01
Scott A P, Radom L. Harmonic vibrational frequencies: An evaluation of hartree-fock, møller-plesset, quadratic configuration interaction, density functional theory, and semiempirical scale factors. J Phys Chem, 1996, 100: 16502–16513
Ocola E J, Brito T, McCann K, et al. Conformational energetics and low-frequency vibrations of cyclohexene and its oxygen analogs. J Mol Struct, 2010, 978: 74–78
Ganguly A, Klaassena J J, Guirgisb G A, et al. Conformational stability, r 0 structural parameters, and vibrational assignments of mono-substituted cyclobutanes: Fluorocyclobutane. Spectrochim Acta Part A, 2011, 79: 831–840
Durig J R, Ganguly A, Defrawy A M E, et al. Conformational stability, r 0 structural parameters, barriers to internal rotation and vibrational assignment of cyclobutylamine. J Mol Struct, 2009, 918: 64–76
Al-Saadi A A, Laane J. Raman and infrared spectra, ab initio and DFT calculations, and vibrational assignments for 2, 3-cyclopenteno-pyridine. Spectrochim Acta Part A, 2008, 71: 326–331
Parlak C. Theoretical and experimental vibrational spectroscopic study of 4-(1-Pyrrolidinyl)piperidine J Mol Struct, 2010, 966: 1–7
Alver Ö, Parlak C. Vibrational spectroscopic investigation and conformational analysis of 1-cyclohexylpiperazine. J Mol Struct, 2010, 975: 85–92
Alver Ö, Parlak C. Vibrational spectroscopic investigation and conformational analysis of 1-pentylamine: A comparative density functional study. J Theor Comput Chem, 2010, 9: 667–685
Alver Ö, Parlak C. DFT, FT-Raman, FT-IR, liquid and solid state NMR studies of 2,6-dimethoxyphenylboronic acid. Vib Spectrosc, 2010, 54: 1–9
Frisch M J, Trucks G W, Schlegel H B, et al. Gaussian 09, Revision A.1. Wallingford: Gaussian Inc., 2009
Dennington R D, Keith T A, Millam J M. GaussView, Version 5.0.8. Wallingford: Gaussian Inc., 2008
Jamróz M H. Vibrational energy distribution analysis: VEDA 4 program. Warsaw. 2004
Pulay P, Forgasi G, Pongor G, et al. Combination of theoretical ab initio and experimental information to obtain reliable harmonic force constants. Scaled quantum mechanical (QM) force fields for glyoxal, acrolein, butadiene, formaldehyde, and ethylene. J Am Chem Soc, 1983, 105: 7037–7047
Jamróz M H, Dobrowolski J C, Brzozowski R. Vibrational modes of 2, 6-, 2, 7-, and 2, 3-diisopropylnaphthalene. A DFT study. J Mol Struct, 2006, 787: 172–183
Keresztury G, Holly S, Varga J, et al. Vibrational spectra of monothiocarbamates. II. IR and Raman spectra, structure, and ab initio force field of S-methyl-N, N-dimethylthiocarbamate. Spectrochim Acta Part A, 1993, 49: 2007–2026
Yokazeki A, Kuchitsu K, Molecular structure of piperazine as studied by gas electron diffraction. Bull Chem Soc Jpn, 1971, 44: 2352–2355
Ji X H, Lu J F. Bis[2-(cyclopentyliminomethyl)-5-methoxyphenola-to]copper(II). Acta Crystallogr Sect E-Struct Rep Online, 2010, E66(8): m881
Hendra P J, Powell D B. The infra-red and Raman spectra of piperazine. Spectrochim Acta, 1962, 18: 299–306
Vedal D, Ellestad O H, Klaboe P, et al. The vibrational spectra of piperidine and morpholine and their N-deuterated analogs. Spectrochim Acta Part A, 1976, 32: 877–890
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bağlayan, Ö., Keşan, G., Parlak, C. et al. Vibrational investigation of 1-cyclopentylpiperazine: A combined experimental and theoretical study. Sci. China Phys. Mech. Astron. 57, 1654–1661 (2014). https://doi.org/10.1007/s11433-013-5313-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11433-013-5313-0